Cargando…

Low Platelet Count Predicts Reduced Survival in Potentially Resectable Hepatocellular Carcinoma

The prognostic role of platelet count in hepatocellular carcinoma (HCC) remains unclear, and in fact both thrombocytopenia and thrombocytosis are reported as predictors of unfavourable outcomes. This study aimed to clarify the prognostic value of preoperative platelet count in potentially resectable...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schrecker, Christopher, Waidmann, Oliver, El Youzouri, Hanan, Trojan, Jörg, Schnitzbauer, Andreas Anton, Bechstein, Wolf Otto, Zeuzem, Stefan, Koch, Christine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947630/ https://www.ncbi.nlm.nih.gov/pubmed/35323324 http://dx.doi.org/10.3390/curroncol29030124

Ejemplares similares

Anti-EGFR Reintroduction and Rechallenge in Metastatic Colorectal Cancer (mCRC): A Real-World Analysis
por: Schulz, Martin S., et al.
Publicado: (2022)

AFP ratio predicts HCC recurrence after liver transplantation
por: Koch, Christine, et al.
Publicado: (2020)

A critical appraisal of the ISGLS definition of biliary leakage after liver resection
por: Sliwinski, Svenja, et al.
Publicado: (2023)

Chemotherapy and Targeted Therapy Strategies in Patients with Unresectable or Borderline Resectable Metastatic Colorectal Cancer: Evidence for a Lack of Focus on Resection Rates
por: Zmuc, Jan, et al.
Publicado: (2023)

Combination of Sorafenib and Transarterial Chemoembolization in Selected Patients with Advanced-Stage Hepatocellular Carcinoma: A Retrospective Cohort Study at Three German Liver Centers
por: Koch, Christine, et al.
Publicado: (2021)

DIALAPP: a prospective validation of a new diagnostic algorithm for acute appendicitis
por: Malkomes, Patrizia, et al.
Publicado: (2020)

Role of regorafenib as second-line therapy and landscape of investigational treatment options in advanced hepatocellular carcinoma
por: Trojan, Jörg, et al.
Publicado: (2016)

Expression of MUC16/CA125 Is Associated with Impaired Survival in Patients with Surgically Resected Cholangiocarcinoma
por: Kinzler, Maximilian N., et al.
Publicado: (2022)

Sarcopenia as a prognostic factor for survival in patients with locally advanced gastroesophageal adenocarcinoma
por: Koch, Christine, et al.
Publicado: (2019)

Circulating hypoxia marker carbonic anhydrase IX (CA9) in patients with hepatocellular carcinoma and patients with cirrhosis
por: Finkelmeier, Fabian, et al.
Publicado: (2018)

Neoadjuvant chemoradiation versus perioperative chemotherapy followed by surgery in resectable adenocarcinomas of the esophagogastric junction: A retrospective single center analysis
por: SCHULZE, BJÖRN, et al.
Publicado: (2014)

Impact of Liver Fibrosis on Survival of Patients with Intrahepatic Cholangiocarcinoma Receiving Gemcitabine-Based Chemotherapy
por: Kinzler, Maximilian N., et al.
Publicado: (2022)

Active Autophagy Is Associated with Favorable Outcome in Patients with Surgically Resected Cholangiocarcinoma
por: Bankov, Katrin, et al.
Publicado: (2023)

Serum MicroRNA-122 Predicts Survival in Patients with Liver Cirrhosis
por: Waidmann, Oliver, et al.
Publicado: (2012)

Serum Sphingolipid Variations Associate with Hepatic Decompensation and Survival in Patients with Cirrhosis
por: Grammatikos, Georgios, et al.
Publicado: (2015)

Serum MicroRNA-21 as Marker for Necroinflammation in Hepatitis C Patients with and without Hepatocellular Carcinoma
por: Bihrer, Verena, et al.
Publicado: (2011)

Colonization with multidrug-resistant organisms impairs survival in patients with hepatocellular carcinoma
por: Himmelsbach, Vera, et al.
Publicado: (2021)

Colonization with multidrug-resistant organisms is associated with in increased mortality in liver transplant candidates
por: Ferstl, Philip G., et al.
Publicado: (2021)

Platelet Count and Survival after Cancer
por: Giannakeas, Vasily, et al.
Publicado: (2022)

Volume and outcome relation in German liver transplant centers: what lessons can be learned?
por: Nijboer, Annemarie, et al.
Publicado: (2014)

Efficacy and Safety of Atezolizumab and Bevacizumab in the Real-World Treatment of Advanced Hepatocellular Carcinoma: Experience from Four Tertiary Centers
por: Himmelsbach, Vera, et al.
Publicado: (2022)

Patient Blood Management improves outcome in oncologic surgery
por: Keding, Vivienne, et al.
Publicado: (2018)

Akutes und chronisches Leberversagen
por: Sarrazin, Christoph, et al.
Publicado: (2014)

Survival According to Therapy Regimen for Small Intestinal Neuroendocrine Tumors
por: Koch, Christine, et al.
Publicado: (2022)

Association between platelet count and hepatocellular carcinoma overall survival: a large retrospective cohort study
por: Lu, Linbin, et al.
Publicado: (2020)

Low 25-Hydroxyvitamin D Levels Are Associated with Infections and Mortality in Patients with Cirrhosis
por: Finkelmeier, Fabian, et al.
Publicado: (2015)

The Correlation Between Platelet Count and Survival in Prostate Cancer
por: Mezei, Tünde, et al.
Publicado: (2022)

Molecular Surveillance of Carbapenem-Resistant Gram-Negative Bacteria in Liver Transplant Candidates
por: Schultze, Tilman G., et al.
Publicado: (2021)

SPTAN1 Expression Predicts Treatment and Survival Outcomes in Colorectal Cancer
por: Schrecker, Christopher, et al.
Publicado: (2021)

Genetic heterogeneity of primary lesion and metastasis in small intestine neuroendocrine tumors
por: Walter, Dirk, et al.
Publicado: (2018)

Kinetics of postdiagnosis platelet count with overall survival of pancreatic cancer: a counting process approach
por: Xiao, Yuanyuan, et al.
Publicado: (2016)

A novel and accurate predictor of survival for patients with hepatocellular carcinoma after surgical resection: the neutrophil to lymphocyte ratio (NLR) combined with the aspartate aminotransferase/platelet count ratio index (APRI)
por: Ji, Fei, et al.
Publicado: (2016)

The Significance of Platelet–Albumin–Bilirubin (PALBI) Grade in Hepatocellular Carcinoma Patients Stratified According to Platelet Count
por: Pang, Qing, et al.
Publicado: (2020)

Serum sphingolipidomic analyses reveal an upregulation of C16- ceramide and sphingosine-1-phosphate in hepatocellular carcinoma
por: Grammatikos, Georgios, et al.
Publicado: (2016)

Cabozantinib for the Treatment of Advanced Hepatocellular Carcinoma: Current Data and Future Perspectives
por: Trojan, Jörg
Publicado: (2020)

Platelet lymphocyte ratio and sarcopenia were associated with survival after hepatocellular carcinoma undergoing curative resection
por: Feng, Xuping, et al.
Publicado: (2022)

Methotrexate and the platelet count.
por: Ogston, D., et al.
Publicado: (1968)

Elevated Platelet Count is Associated with Poor Survival After Transarterial Chemoembolization Treatment in Patients with Hepatocellular Carcinoma: A Cohort Study
por: Lu, linbin, et al.
Publicado: (2020)

The clinical significance of preoperative plasma fibrinogen levels and platelet counts in resectable colon cancer
por: Papila Kundaktepe, Berrin, et al.
Publicado: (2021)

Accuracy of Hepatobiliary Scintigraphy after Liver Transplantation and Liver Resection
por: Eckenschwiller, Manuel, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_7p6l5n5sfsc98t21h4oo567r7k